Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Gross Profit (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Gross Profit for 16 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit fell 63.58% year-over-year to $2.3 million, compared with a TTM value of $11.4 million through Sep 2025, down 31.54%, and an annual FY2024 reading of $17.5 million, up 100.87% over the prior year.
  • Gross Profit was $2.3 million for Q3 2025 at Rockwell Medical, down from $2.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $6.2 million in Q3 2024 and bottomed at -$2.2 million in Q4 2021.
  • Average Gross Profit over 5 years is $1.9 million, with a median of $2.3 million recorded in 2025.
  • The sharpest move saw Gross Profit plummeted 679.22% in 2021, then soared 766.03% in 2022.
  • Year by year, Gross Profit stood at -$2.2 million in 2021, then surged by 204.98% to $2.3 million in 2022, then grew by 22.6% to $2.9 million in 2023, then increased by 26.52% to $3.6 million in 2024, then plummeted by 37.43% to $2.3 million in 2025.
  • Business Quant data shows Gross Profit for RMTI at $2.3 million in Q3 2025, $2.5 million in Q2 2025, and $3.0 million in Q1 2025.